-
EP3728250
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3728250
| EP3728250 - PYRAZOLO[3,4-BETA]PYRIDINES AND IMIDAZO[1,5-BETA]PYRIDAZINES AS PDE1 INHIBITORS [Right-click to bookmark this link] | |||
| Former [2020/44] | PYRAZOLO[3,4-beta]PYRIDINES AND IMIDAZO[1,5-beta]PYRIDAZINES AS PDE1 INHIBITORS | ||
| [2024/34] | Status | Examination is in progress Status updated on 09.07.2021 Database last updated on 29.07.2024 | |
| Former | Request for examination was made Status updated on 25.09.2020 | ||
| Former | The international publication has been made Status updated on 29.06.2019 | ||
| Former | unknown Status updated on 15.01.2019 | Most recent event Tooltip | 19.07.2024 | Change - English title | published on 21.08.2024 [2024/34] | 19.07.2024 | Change - French title | published on 21.08.2024 [2024/34] | Applicant(s) | For all designated states H. Lundbeck A/S Ottiliavej 9 2500 Valby / DK | [2020/44] | Inventor(s) | 01 /
KEHLER, Jan c/o H. Lundbeck A/S Ottiliavej 9 2500 Valby / DK | 02 /
RASMUSSEN, Lars, Kyhn c/o H. Lundbeck A/S Ottiliavej 9 2500 Valby / DK | 03 /
LANGGÅRD, Morten c/o H. Lundbeck A/S Ottiliavej 9 2500 Valby / DK | 04 /
JESSING, Mikkel c/o H. Lundbeck A/S Ottiliavej 9 2500 Valby / DK | 05 /
VITAL, Paulo, Jorge, Vieira c/o H. Lundbeck A/S Ottiliavej 9 2500 Valby / DK | 06 /
JUHL, Karsten c/o H. Lundbeck A/S Ottiliavej 9 2500 Valby / DK | 07 /
MARIGO, Mauro c/o H. Lundbeck A/S Ottiliavej 9 2500 Valby / DK | [2020/44] | Representative(s) | H. Lundbeck A/S Ottiliavej 9 2500 Valby / DK | [2020/44] | Application number, filing date | 18829814.5 | 19.12.2018 | [2020/44] | WO2018EP85725 | Priority number, date | DK2017PA00729 | 20.12.2017 Original published format: DK PA201700729 | [2020/44] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019121840 | Date: | 27.06.2019 | Language: | EN | [2019/26] | Type: | A1 Application with search report | No.: | EP3728250 | Date: | 28.10.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 27.06.2019 takes the place of the publication of the European patent application. | [2020/44] | Search report(s) | International search report - published on: | EP | 27.06.2019 | Classification | IPC: | C07D471/04, C07D487/04, A61P25/28, A61K31/437, A61K31/519, C07D519/00 | [2020/44] | CPC: |
C07D471/04 (EP);
C07D487/04 (EP,CN);
C07D405/14 (US);
A61K31/519 (EP);
A61P25/14 (CN);
A61P25/18 (CN);
A61P25/22 (CN);
A61P25/24 (CN);
A61P25/28 (EP,CN);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/44] | Title | German: | PYRAZOLO[3,4-BETA]PYRIDINE UND IMIDAZO[1,5-BETA]PYRIDAZINE ALS PDE1-INHIBITOREN | [2020/44] | English: | PYRAZOLO[3,4-BETA]PYRIDINES AND IMIDAZO[1,5-BETA]PYRIDAZINES AS PDE1 INHIBITORS | [2024/34] | French: | PYRAZOLO[3,4-BETA]PYRIDINES ET IMIDAZO[1,5-BETA]PYRIDAZINES UTILISÉES EN TANT QU'INHIBITEURS DE PDE1 | [2024/34] |
| Former [2020/44] | PYRAZOLO[3,4-beta]PYRIDINES AND IMIDAZO[1,5-beta]PYRIDAZINES AS PDE1 INHIBITORS | ||
| Former [2020/44] | PYRAZOLO[3,4-beta]PYRIDINES ET IMIDAZO[1,5-beta]PYRIDAZINES UTILISÉES EN TANT QU'INHIBITEURS DE PDE1 | Entry into regional phase | 20.07.2020 | National basic fee paid | 20.07.2020 | Designation fee(s) paid | 20.07.2020 | Examination fee paid | Examination procedure | 20.07.2020 | Examination requested [2020/44] | 20.07.2020 | Date on which the examining division has become responsible | 14.01.2021 | Amendment by applicant (claims and/or description) | 12.07.2021 | Despatch of a communication from the examining division (Time limit: M06) | 06.01.2022 | Reply to a communication from the examining division | 10.05.2022 | Despatch of a communication from the examining division (Time limit: M06) | 03.11.2022 | Reply to a communication from the examining division | 27.06.2023 | Despatch of a communication from the examining division (Time limit: M04) | 24.10.2023 | Reply to a communication from the examining division | Fees paid | Renewal fee | 11.01.2021 | Renewal fee patent year 03 | 03.01.2022 | Renewal fee patent year 04 | 02.01.2023 | Renewal fee patent year 05 | 02.01.2024 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [AD]WO2016055618 (LUNDBECK & CO AS H [DK]); | [A]WO2017024004 (SAMUMED LLC [US]); | [XPI]WO2018007249 (H LUNDBECK AS [DK]); | by applicant | WO2008070095 | WO2013142307 | WO2016042775 | US2016083391 | US2016083400 | WO2016055618 | WO2016147659 | WO2016170064 | WO2016174188 |